Phosphoramidon inhibition of the in vivo conversion of big endothelin‐1 to endothelin‐1 in the human forearm

British Journal of Pharmacology

Volumn 116, Issue 2, 1995, Pages 1821-1828

  Plumpton, Christopher ^c   Haynes, William G ^a,b   Webb, David J ^a,b   Davenport, Anthony P ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c NONE

Author keywords

big endothelin; Endothelin; endothelin converting enzyme; human brachial artery; phosphoramidon; radioimmunoassay; selective solid phase extraction; vasoconstriction

Indexed keywords

BIG ENDOTHELIN 1; ENDOTHELIN 1; ENDOTHELIN CONVERTING ENZYME; PHOSPHORAMIDON; VASOCONSTRICTOR AGENT;

ADULT; ARTICLE; BLOOD LEVEL; BRACHIAL ARTERY; CONTROLLED STUDY; FOREARM; FOREARM BLOOD FLOW; HUMAN; HUMAN EXPERIMENT; MALE; METHODOLOGY; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; RADIOIMMUNOASSAY; VASOCONSTRICTION; VENOUS BLOOD;

ADULT; BRACHIAL ARTERY; ENDOTHELINS; FOREARM; GLYCOPEPTIDES; HUMAN; MALE; PROTEASE INHIBITORS; RADIOIMMUNOASSAY; SUPPORT, NON-U.S. GOV'T; TIME FACTORS; VOLUNTARY WORKERS;

EID: 0029093717     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1995.tb16669.x     Document Type: Article

References (42)

1. Big ET‐1 infusion in man causes renal ET‐1 release, renal and splanchnic vasoconstriction, and increased mean aterial blood pressure
2. Recent developments in endothelin research
3. Endothelin is a potent long‐lasting vasoconstrictor in men
4. Radioimmunoassay evidence that the pressor effect of big endothelin‐1 in anaesthetised rats is due to local conversion to endothelin‐1
5. A sensitive radioimmunoassay measuring endothelin‐like immunoreactivity in human plasma: comparison of levels in patients with essential hypertension and normotensive control subjects
6. A receptors in man
7. Localisation of binding sites for iodinated endothelin and sarafotoxin peptides using quantitative receptor autoradiography
8. 125I] endothelin‐1 in humans, pigs and rats: functional relevance in man
9. A subtype
10. Why are circulating concentrations of endothelin‐1 so low
11. Inhibition of biological actions of big endothelin‐1 by phosphoramidon
12. The effects of phosphoramidon on the regional haemodynamic responses to human proendothelin [1–38] in conscious rats
13. Contribution of endogenous generation of endothelin‐1 to basal vascular tone
14. Regional extraction of endothelins and conversion of big endothelin to endothelin‐1 in the pig
15. Characterisation of endothelin secretion by vascular endothelial cells
16. Anatomical localisation and pharmacological activity of mature endothelins and their precursors in human vascular tissue
17. Phosphoramidon, a metalloproteinase inhibitor, suppresses the secretion of endothelin‐1 from cultured endothelial cells by inhibiting a big endothelin‐1 converting enzyme
18. cDNA cloning and expression of bovine endothelin converting enzyme
19. Distribution and molecular form of immunoreactive big endothelin‐1 in porcine tissue
20. Presence of Furin mRNA in cultured bovine endothelial cells and possible involvement of Furin in the processing of the endothelin precursor
21. A receptor‐mediated constrictor responses to endothelin peptides in human blood vessels in vitro
22. Phosphoramidon blocks the pressor activity of big endothelial‐39] and lowers blood pressure in spontaneously hypertensive rats
23. Characterisation and localisation of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium
24. Endothelins 1 and 3 and big endothelin‐1 contract isolated human placental veins
25. Generation by the phosphoramidon‐sensitive peptidases, endo‐peptidase‐24.11 and thermolysin, of endothelin‐1 and C‐terminal fragment from big endothelin‐1
26. Conversion of big endothelin isopeptides to mature endothelin isopeptides by cultured bovine endothelial cells
27. Endothelin‐converting enzymes
28. Potent vasoconstrictor effects and clearance of endothelin in the human forearm
29. Characterisation of endothelin isoforms in human heart: Endothelin‐2 demonstrated
30. Phosphoramidon inhibits the in vivo conversion of big ET‐1 to ET in man
31. Effects of phosphoramidon and pepstatin A on the secretion of endothelin‐1 and big endothelin‐1 by human umbilical vein endothelial cells: measurement by two‐site enzyme‐linked immunosorbent assays
32. Analysis of endothelin related peptides in culture supernatant of porcine aortic endothelial cells: evidence for biosynthetic pathway of endothelin‐1
33. Molecular characterization of human and bovine endothelin converting enzyme
34. A comparative study of the various tests for normality
35. Cloning and functional expression of endothelin‐converting enzyme from rat endothelial cells
36. Endothelins are more sensitive than sarafotoxins to neutral endopeptidase: Possible physiological significance
37. A sandwich‐type enzyme immunoassay to detect immunoreactive big‐endothelin‐1 in plasma
38. Endothelin‐converting enzymes and other families of metallo‐endopeptidases
39. Is big endothelin converted to endothelin‐1 in circulating blood
40. Long‐lasting vasoconstriction and efficient regional extraction of endothelin‐1 in human splanchnic and renal tissues
41. ECE‐1: A membrane‐bound metalloprotease that catalyzes the proteolytic activation of big endothelin‐1
42. A novel potent vasoconstrictor peptide produced by vascular endothelial cells